YOLFTbeta
Kolon Life Science Inc

Kolon Life Science Inc

102940 · KQ · Healthcare / Pharmaceuticals

12,030.00KRW-110.00 (-0.91%)

Price History

Full chart

Market Stats

Previous Close12,140.00
Open12,150.00
Day Range11,960.00 – 12,430.00
52-Week Range13,210.00 – 72,700.00
Volume49.93K
Market Cap188.37B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta1.13
50-Day Avg15,228.40
200-Day Avg43,815.05

About

Kolon Life Science Inc. provides biopharmaceuticals, active pharmaceutical ingredients, pyrithione antimicrobials, and water solutions primarily in South Korea. Its biopharmaceutical product under development comprise KLS-1020, a cancer vaccine; KLS-3021, a oncolytic viral therapy; and KLS-2031 for treatment for neuropathic pain. The company also provides active pharmaceutical ingredients for anti-cancer and intermediates; and pyrithione antimicrobial for shampoo and soap bars, cosmetic and wet wipes, fabric softeners, metalworking fluids, antifouling paints, and fire-fighters. In addition, it offers Kolon BESFLOC polymer used in chemical, food, leather, pharmaceutical, textile, and dairy industries, as well as in settling reservoirs, sludge thickeners, floating reservoirs, and dehydrators in sewage treatment plants. The company was formerly known as Korea Tissuegene Asia, Ltd. and changed its name to Kolon Life Science Inc. in January 2006. Kolon Life Science Inc. was founded in 2000 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryPharmaceuticals
  • CEOMr. Woo-Sok Lee
  • Employees433
  • HeadquartersOne & Only Tower, Seoul, South Korea, Korea
  • Websitehttps://www.kolonls.co.kr

Leadership

  • Mr. Woo-Sok LeeChief Exec. Officer · b. 1957
  • Mr. Mun-Hee ParkChief Exec. Officer
  • Mr. Tae-Hwan KimPres · b. 1950
  • Sang-Jun LeeChief Operating Officer and Vice-Pres · b. 1961
  • Sang-Hu ParkManaging Director and Laboratory Director · b. 1962
  • Myung-Kwan SuhManaging Director and Director of Management Support Division · b. 1962
  • Sang-Woo LeeManaging Director and Director of Quality Management · b. 1964

Financials

Income Statement

Currency: KRW2011-12-312012-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue--130.63B121.18B158.28B118.10B132.68B148.54B129.41B165.49B161.58B124.64B161.39B208.98B
Growth (%)----7.24%+30.62%-25.39%+12.34%+11.95%-12.88%+27.87%-2.36%-22.86%+29.48%+29.49%
Cost of Revenue--97.62B95.28B109.69B89.45B121.95B122.98B110.52B128.28B124.45B112.23B144.52B153.09B
Gross Profit--33.02B25.89B48.60B28.65B10.73B25.56B18.90B37.20B37.14B12.41B16.87B55.89B
Gross Margin--25.27%21.37%30.70%24.26%8.09%17.21%14.60%22.48%22.98%9.96%10.45%26.74%
Operating Expense--23.62B23.71B30.30B34.19B62.75B54.31B45.92B37.66B37.38B39.64B75.03B41.09B
Operating Income--9.40B2.18B18.30B-5.54B-52.03B-28.75B-27.03B-453.60M-239.25M-27.23B-58.16B14.81B
Operating Margin--7.19%1.80%11.56%-4.69%-39.21%-19.36%-20.88%-0.27%-0.15%-21.85%-36.04%7.08%
EBITDA----------17.31B-18.91B-76.80B43.30B
EBITDA Margin----------10.71%-15.17%-47.59%20.72%
Net Income--5.86B800.14M12.67B-1.40B-50.69B-92.32B-43.20B-1.37B2.13B-30.73B-93.09B24.96B
Net Income Margin--4.48%0.66%8.00%-1.19%-38.20%-62.15%-33.38%-0.83%1.32%-24.65%-57.68%11.94%
R&D--9.70B8.85B11.04B13.71B19.42B18.49B13.15B14.33B13.60B14.89B16.44B13.91B
R&D as % of Total Revenue--7.43%7.30%6.97%11.61%14.64%12.45%10.16%8.66%8.41%11.95%10.19%6.65%
Interest Expense000000005.52B6.01B3.72B5.86B7.41B7.78B
Interest Expense % of Total Revenue--0.00%0.00%0.00%0.00%0.00%0.00%4.26%3.63%2.31%4.70%4.59%3.72%

Balance Sheet

Currency: KRW2011-12-312012-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets--208.90B228.62B354.57B716.80B618.90B278.29B248.34B234.66B314.12B309.44B419.56B914.41B
Total Liabilities--72.72B93.17B94.78B171.38B172.76B177.27B190.38B135.25B146.39B171.76B270.23B330.38B
Total Equity--136.17B135.44B259.79B545.41B446.15B101.02B57.96B99.41B167.72B137.67B149.34B584.03B
Cash--5.06B27.01B137.74B55.83B32.67B5.91B15.00B27.80B6.37B7.56B12.50B10.64B
Total Debt---59.82B32.07B40.81B57.56B71.98B71.35B-----
Net Debt--------61.42B40.60B67.09B99.68B112.08B91.51B

Cash Flow

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow11.65B23.37B-12.10B20.81B28.11B-8.29B-13.60B-20.18B-7.31B-16.19B-20.85B-24.87B-14.08B10.21B
Investing Cash Flow-25.02B-65.31B--28.66B-15.64B-17.23B-60.23B-25.12B-19.61B19.04B-2.25B-5.94B-7.03B-6.38B-
Financing Cash Flow37.41B19.07B-1.68B16.83B99.61B-13.19B15.46B13.01B-2.38B30.95B5.46B32.89B24.78B-
Capital Expenditure27.52B61.01B015.01B15.22B16.14B29.98B42.44B30.78B2.74B4.41B6.31B10.24B8.73B38.39B
Free Cash Flow----------10.05B-20.64B-27.16B-35.10B-22.81B-28.18B
Dividends Paid20.40M21.41M-105.45M1.34B668.29M1.52B--------
FCF to OCF---------137.54%127.53%130.25%141.17%161.96%-276.01%

Earnings

Report DateJun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Nov 30, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Sep 3, 2014Dec 3, 2014Feb 25, 2015May 15, 2015Aug 13, 2015Oct 23, 2015Jan 19, 2016May 2, 2016Aug 2, 2016Nov 7, 2016Feb 7, 2017May 15, 2017Aug 11, 2017Nov 14, 2017Jan 31, 2018May 15, 2018Aug 14, 2018Nov 14, 2018Feb 11, 2019May 15, 2019Aug 14, 2019Nov 14, 2019Feb 7, 2020May 15, 2020Aug 13, 2020Nov 16, 2020May 20, 2021Aug 26, 2021Nov 25, 2021May 16, 2022May 15, 2023Aug 11, 2023Nov 14, 2023Mar 28, 2024May 16, 2024Aug 14, 2024Nov 12, 2024Feb 18, 2025May 15, 2025Aug 12, 2025Nov 12, 2025Dec 31, 2025May 13, 2026Jun 30, 2026
EPS Estimate-----------------------207.33207.33---------------13.57------------------------
EPS Actual342.07334.1534.29242.46212.27263.93336.12141.96353.33374.29488.78579.66714.85553.18168.17916.05452.54258.7395.41247.74190.4953.2982.03207.3310.67-38.32175.37203.17228.05210.57510.9924.1063.00-79.33-196.08-221.00-268.98-397.94-783.00-6031.00-3483.00-755.38-629.97-257.00-428.00285.00-3388.88566.1268.26-735.26-45.11-493.78-614.70-1175.56-398.10-5147.00-1009.00-1347.10843.65-119.651794.00-741.911592.60-166.96
Surprise-----------------------0.00%-94.85%---------------44343.63%------------------------
Timing-----------------------After-hoursAfter-hoursPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market---Pre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-market-Pre-market-

Key Statistics & Ratios

Market Cap188.37B
Enterprise Value307.86B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.94
Price / Book0.26
Revenue (TTM)190.61B
Gross Profit (TTM)37.10B
EBITDA11.63B
Profit Margin-3.01%
Operating Margin0.69%
Return on Equity-3385.96%
Return on Assets0.34%
Shares Outstanding11.41M
Shares Float7.35M
Beta1.13
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20161×
133.33Dec 28, 2016
20151×
64.60Dec 29, 2015
20141×
129.19Dec 29, 2014
20131×
12.92Dec 27, 2013
20121×
403.73Dec 27, 2012
20111×
2.69Dec 28, 2011
20101×
2.56Dec 29, 2010
20091×
2.49Dec 29, 2009

Stock Splits

  • Dec 27, 20173:2
  • May 2, 20162061:1997
  • Dec 27, 20136:5
  • Dec 28, 201121:20
  • Dec 29, 2010103:100
  • Dec 29, 200951:50